Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage. | Oncogene | 2023 | 36922678 | PubTator, text mining | PubMed |
| Caspase Cleavage of Receptor Tyrosine Kinases in the Dependence Receptor Family. | Biomol Ther (Seoul) | 2023 | 36919636 | PubTator, text mining | PubMed |
| Co-expression network of mRNA and DNA methylation in first-episode and drug-naive adolescents with major depressive disorder. | Front Psychiatry | 2023 | 36911124 | PubTator, text mining | PubMed |
| Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies. | Mol Ther Oncolytics | 2023 | 36911068 | PubTator, text mining | PubMed |
| Natural Products in Precision Oncology: Plant-Based Small Molecule Inhibitors of Protein Kinases for Cancer Chemoprevention. | Nutrients | 2023 | 36904191 | PubTator, text mining | PubMed |
| The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans. | Cancers (Basel) | 2023 | 36900315 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance. | Cells | 2023 | 36899938 | PubTator, text mining | PubMed |
| COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels. | Cells | 2023 | 36899820 | PubTator, text mining | PubMed |
| Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis. | Redox Biol | 2023 | 36889082 | PubTator, text mining | PubMed |
| A mad yearning for solitude: Timon the Misanthrope and his relevance to the study of ancient psychopathology. | Hist Psychiatry | 2023 | 36876402 | PubTator, text mining | PubMed |
| Compression Stress-Induced Internal Magnetic Field in Bulky TiO2 Photoanodes for Enhancing Charge-Carrier Dynamics. | JACS Au | 2023 | 36873698 | PubTator, text mining | PubMed |
| Co-occurring pathogenic variants in 6q27 associated with dementia spectrum disorders in a Peruvian family. | Front Mol Neurosci | 2023 | 36873109 | PubTator, text mining | PubMed |
| Radiation prevents tumor progression by inhibiting the miR‑93‑5p/EphA4/NF‑κB pathway in triple‑negative breast cancer. | Oncol Rep | 2023 | 36866759 | PubTator, text mining | PubMed |
| A circuit for secretion-coupled cellular autonomy in multicellular eukaryotic cells. | Mol Syst Biol | 2023 | 36856068 | PubTator, text mining | PubMed |
| A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX. | Immunotargets Ther | 2023 | 36844460 | PubTator, text mining | PubMed |
| Emerging Role of Plant-Based Dietary Components in Post-Translational Modifications Associated with Colorectal Cancer. | Life (Basel) | 2023 | 36836621 | PubTator, text mining | PubMed |
| Alzheimer's Disease: An Updated Overview of Its Genetics. | Int J Mol Sci | 2023 | 36835161 | PubTator, text mining | PubMed |
The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling. | Int J Mol Sci | 2023 | 36835041 | PubTator, text mining | PubMed |
| Histone Modifications in Alzheimer's Disease. | Genes (Basel) | 2023 | 36833274 | PubTator, text mining | PubMed |
| An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4. | Cancers (Basel) | 2023 | 36831617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=14